CVS Caremark Corporation (NYSE:CVS) – CVS Caremark Research Finds Eliminating Medication Copays Post-Heart Attack Can Improve Health Outcomes for Non-White Patients

[PR Newswire] – WOONSOCKET, R.I., May 5, 2014 /PRNewswire/ — A new study by researchers at CVS Caremark (CVS), Aetna and Brigham and Women’s Hospital published today in the May issue of Health . . . → Read More: CVS Caremark Corporation (NYSE:CVS) – CVS Caremark Research Finds Eliminating Medication Copays Post-Heart Attack Can Improve Health Outcomes for Non-White Patients Similar Articles: CVS Caremark Corporation (NYSE:CVS) | Study Commissioned by CVS Caremark Highlights Opportunities to Significantly Reduce Spending on Costly Specialty Medications Market Update (NYSE:CVS): CVS Caremark Finalizes Previously Announced Settlement with Securities and Exchange Commission CVS Caremark Corporation (NYSE:CVS) – CVS Caremark Awarded Integrated, 3-Year Blue Cross and Blue Shield Federal Employee Program (FEP) Contract